Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ESSA Pharma Inc. | 200,000 | reported | 25 Mar 2024 | tx 3+347,500 |
| PUMA BIOTECHNOLOGY, INC. | 41,850 | reported | 18 Jul 2025 | tx 6+181,000−39,150 |
| Summit Therapeutics Inc. | 35,000 | reported | 02 Jan 2026 | tx 10+388,171 |
| Zymeworks Inc. | 11,500 | reported | 12 Jan 2026 | tx 4+124,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 7,700 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 11,500 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 02 Jan 2026 | GRANT_AWARD | Summit Therapeutics Inc. | 3,219 | 8.76 USD | deriv |
| 18 Jul 2025 | SALE | PUMA BIOTECHNOLOGY, INC. | 27,000 | 3.37 USD | |
| 13 Jun 2025 | SALE | PUMA BIOTECHNOLOGY, INC. | 12,150 | 3.40 USD | |
| 11 Jun 2025 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 3,073 | 9.18 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | Zymeworks Inc. | 31,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 25 Mar 2024 | GRANT_AWARD | ESSA Pharma Inc. | 200,000 | 0.00 USD | deriv |
| 08 Feb 2024 | GRANT_AWARD | Zymeworks Inc. | 74,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 02 Jan 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 21,363 | 1.32 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 27,000 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | Summit Therapeutics Inc. | 35,000 | — | deriv |
| 03 Jan 2023 | GRANT_AWARD | Summit Therapeutics Inc. | 16,350 | 1.67 USD | deriv |
| 15 Nov 2022 | GRANT_AWARD | Summit Therapeutics Inc. | 4,166 | — | deriv |
| 15 Nov 2022 | GRANT_AWARD | Summit Therapeutics Inc. | 200,000 | — | deriv |
| 29 Jun 2022 | GRANT_AWARD | ESSA Pharma Inc. | 90,000 | 0.00 USD | deriv |
| 29 Jul 2022 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 100,000 | 0.00 USD | deriv |
| 11 Dec 2020 | GRANT_AWARD | ESSA Pharma Inc. | 57,500 | 0.00 USD | deriv |